Gender difference in plasma fatty-acid-binding protein 4 levels in patients with chronic obstructive pulmonary disease

Bioscience Reports

Volumn 36, Issue 1, 2016, Pages

  Zhang, Xue ^a   Li, Diandian ^a   Wang, Hao ^a   Pang, Caishuang ^a   Wu, Yanqiu ^a   Wen, Fuqiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; Fatty acid binding protein 4; Inflammation; Lung function

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FATTY ACID BINDING PROTEIN 4; TUMOR NECROSIS FACTOR ALPHA; ADIPOCYTOKINE; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; PATHOGENESIS; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; SEX DIFFERENCE; BLOOD; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SEXUAL DEVELOPMENT;

ADIPOKINES; C-REACTIVE PROTEIN; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX CHARACTERISTICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84960092686     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20150281     Document Type: Article

References (39)

1. Vestbo, J., Hurd, S.S., Agusti, A.G., Jones, P.W., Vogelmeier, C., Anzueto, A., Barnes, P.J., Fabbri, L.M., Martinez, F.J., Nishimura, M. et al. (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 187, 347-365 CrossRef PubMed
2. Hodgson, D.B., Saini, G., Bolton, C.E. and Steiner, M.C. (2012) Thorax in focus: chronic obstructive pulmonary disease. Thorax 67, 171-176 CrossRef PubMed
3. Sethi, S., Mahler, D.A., Marcus, P., Owen, C.A., Yawn, B. and Rennard, S. (2012) Inflammation in COPD: implications for management. Am. J. Med. 125, 1162-1170 CrossRef PubMed
4. Holloway, R.A. and Donnelly, L.E. (2013) Immunopathogenesis of chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 19, 95-102 CrossRef PubMed
5. Huertas, A. and Palange, P. (2011) COPD: a multifactorial systemic disease. Ther. Adv. Respir. Dis. 5, 217-224 CrossRef PubMed
6. Carolan, B.J., Kim, Y.I., Williams, A.A., Kechris, K., Lutz, S., Reisdorph, N. and Bowler, R.P. (2013) The association of adiponectin with computed tomography phenotypes in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 188, 561-566 CrossRef PubMed
7. Chan, K.H., Yeung, S.C., Yao, T.J., Ip, M.S., Cheung, A.H., Chan-Yeung, M.M. and Mak, J.C. (2010) Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease. Int. J. Tuberc. Lung Dis. 14, 1193-1200 PubMed
8. Thumser, A.E., Moore, J.B. and Plant, N.J. (2014) Fatty acid binding proteins: tissue-specific functions in health and disease. Curr. Opin. Clin. Nutr. Metab. Care 17, 124-129 CrossRef PubMed
9. Kralisch, S. and Fasshauer, M. (2013) Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia 56, 10-21 CrossRef PubMed
10. Terra, X., Quintero, Y., Auguet, T., Porras, J.A., Hernández, M., Sabench, F., Aguilar, C., Luna, A.M., Del Castillo, D. and Richart, C. (2011) FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women. Eur. J. Endocrinol. 164, 539-547 CrossRef PubMed
11. Lazra, Y., Falach, A., Frenkel, L., Rozenberg, K., Sampson, S. and Rosenzweig, T. (2014) Autocrine/paracrine function of globular adiponectin: inhibition of lipid metabolism and inflammatory response in 3T3-L1 adipocytes. J. Cell. Biochem. 116, 754-766 CrossRef
12. Xu, H., Hertzel, A.V., Steen, K.A., Wang, Q., Suttles, J. and Bernlohr, D.A. (2015) Uncoupling lipid metabolism from inflammation through FABP-dependent expression of UCP2. Mol. Cell. Biol. 35, 1055-1065 CrossRef PubMed
13. Ghelfi, E., Karaaslan, C., Berkelhamer, S., Akar, S., Kozakewich, H. and Cataltepe, S. (2011) Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia. Am. J. Respir. Cell Mol. Biol. 45, 550-556 CrossRef PubMed
14. Shum, B.O., Mackay, C.R., Gorgun, C.Z., Frost, M.J., Kumar, R.K., Hotamisligil, G.S. and Rolph, M.S. (2006) The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation. J. Clin. Invest. 116, 2183-2192 CrossRef PubMed
15. Makowski, L., Boord, J.B., Maeda, K., Babaev, V.R., Uysal, K.T., Morgan, M.A., Parker, R.A., Suttles, J., Fazio, S., Hotamisligil, G.S. and Linton, M.F. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med. 7, 699-705 CrossRef PubMed
16. Parra, S., Cabré, A., Marimon, F., Ferré, R., Ribalta, J., Gonzàlez, M., Heras, M., Castro, A. and Masana, L. (2014) Circulating FABP4 is a marker of metabolic and cardiovascular risk in SLE patients. Lupus 23, 245-254 CrossRef PubMed
17. Català, R., Cabré, A., Hernández-Flix, S., Ferré, R., Sangenís, S., Plana, N., Texidó, A. and Masana, L. (2013) Circulating FABP4 and FABP5 levels are differently linked to OSA severity and treatment. Sleep 36, 1831-1837 PubMed
18. Soriano, J.B., Visick, G.T., Muellerova, H., Payvandi, N. and Hansell, A.L. (2005) Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 128, 2099-2107 CrossRef PubMed
19. Meijer, M., Rijkers, G.T. and van Overveld, F.J. (2013) Neutrophils and emerging targets for treatment in chronic obstructive pulmonary disease. Expert Rev. Clin. Immunol. 9, 1055-1068 CrossRef PubMed
20. Vlahos, R. and Bozinovski, S. (2014) Role of alveolar macrophages in chronic obstructive pulmonary disease. Front. Immunol. 5, 435 CrossRef PubMed
21. Makowski, L., Brittingham, K.C., Reynolds, J.M., Suttles, J. and Hotamisligil, G.S. (2005) The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity: macrophage expression of aP2 impacts peroxisome proliferator-activated receptor γ and IκB kinase activities. J. Biol. Chem. 280, 12888-12895 CrossRef PubMed
22. Chung, K.F. and Adcock, I.M. (2008) Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur. Respir. J. 31, 1334-1356 CrossRef PubMed
23. Ghelfi, E., Yu, C.W., Elmasri, H., Terwelp, M., Lee, C.G., Bhandari, V., Comhair, S.A., Erzurum, S.C., Hotamisligil, G.S., Elias, J.A. and Cataltepe, S. (2013) Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma. Am. J. Pathol. 182, 1425-1433 CrossRef PubMed
24. Shen, Y., Yang, T., Guo, S., Li, X., Chen, L., Wang, T. and Wen, F. (2013) Increased serum ox-LDL levels correlated with lung function, inflammation, and oxidative stress in COPD. Mediators Inflamm. 2013, 972347 PubMed
25. Fu, Y., Luo, L., Luo, N. and Garvey, W.T. (2006) Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages. Atherosclerosis 188, 102-111 CrossRef PubMed
26. Fu, Y., Luo, N. and Lopes-Virella, M.F. (2000) Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J. Lipid Res. 41, 2017-2023 PubMed
27. Yeung, D.C., Xu, A., Cheung, C.W., Wat, N.M., Yau, M.H., Fong, C.H., Chau, M.T. and Lam, K.S. (2007) Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 1796-1802 CrossRef PubMed
28. Fisher, R.M., Eriksson, P., Hoffstedt, J., Hotamisligil, G.S., Thörne, A., Rydén, M., Hamsten, A. and Arner, P. (2001) Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia 44, 1268-1273 CrossRef PubMed
29. Furuhashi, M., Saitoh, S., Shimamoto, K. and Miura, T. (2014) Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin. Med. Insights Cardiol. 8, 23-33 PubMed
30. Doʇanay, M., Ozyer, S.S., Var, T., Tonguc, E., Gun Eryilmaz, O., Ozer, I. and Guzel, A.I. (2015) Associations between adipocyte fatty acid-binding protein and clinical parameters in polycystic ovary syndrome. Arch. Gynecol. Obstet. 291, 447-450 CrossRef PubMed
31. Hillas, G., Perlikos, F., Tsiligianni, I. and Tzanakis, N. (2015) Managing comorbidities in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 10, 95-109 PubMed
32. Hotamisligil, G.S., Johnson, R.S., Distel, R.J., Ellis, R., Papaioannou, V.E. and Spiegelman, B.M. (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274, 1377-1379 CrossRef PubMed
33. -/- mice. J. Cell. Mol. Med. 17, 303-310 CrossRef PubMed
34. Caselli, C., D'Amico, A., Cabiati, M., Prescimone, T., Del Ry, S. and Giannessi, D. (2014) Back to the heart: the protective role of adiponectin. Pharmacol. Res. 82, 9-20 CrossRef PubMed
35. Breyer, M.K., Rutten, E.P., Vernooy, J.H., Spruit, M.A., Dentener, M.A., van der Kallen, C., vanGreevenbroek, M.M. and Wouters, E.F. (2011) Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin. Respir. Med. 105, 1046-1053 CrossRef PubMed
36. Thorleifsson, S.J., Margretardottir, O.B., Gudmundsson, G., Olafsson, I., Benediktsdottir, B., Janson, C., Buist, A.S. and Gislason, T. (2009) Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. Respir. Med. 103, 1548-1553 CrossRef PubMed
37. Garcia-Rio, F., Miravitlles, M., Soriano, J.B., Muñoz, L., Duran-Tauleria, E., Sánchez, G., Sobradillo, V. and Ancochea, J. (2010) Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir. Res. 11, 63 CrossRef PubMed
38. Simón, I., Escoté, X., Vilarrasa, N., Gómez, J., Fernández-Real, J.M., Megía, A., Gutiérrez, C., Gallart, L., Masdevall, C. and Vendrell, J. (2009) Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women. Obesity 17, 1124-1128 PubMed
39. Bagheri, R., Qasim, A.N., Mehta, N.N., Terembula, K., Kapoor, S., Braunstein, S., Schutta, M., Iqbal, N., Lehrke, M. and Reilly, M.P. (2010) Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with Type-2 diabetes mellitus. Am. J. Cardiol. 106, 1118-1123 CrossRef PubMed